Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.

Le Péchoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche A; Prophylactic Cranial Irradiation (PCI) Collaborative Group.

Lancet Oncol. 2009 May;10(5):467-74. doi: 10.1016/S1470-2045(09)70101-9. Epub 2009 Apr 20.

PMID:
19386548
[PubMed - indexed for MEDLINE]
2.

Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.

De Ruysscher D, Dehing C, Bremer RH, Bentzen SM, Koppe F, Pijls-Johannesma M, Harzée L, Minken A, Wanders R, Hochstenbag M, Dingemans AM, Boersma L, van Haren E, Geraedts W, Pitz C, Simons J, Wouters B, Rosier JF, Lambin P.

Ann Oncol. 2007 May;18(5):909-16. Epub 2007 Feb 23.

PMID:
17322546
[PubMed - indexed for MEDLINE]
Free Article
3.

Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting.

Horsman MR, Bohm L, Margison GP, Milas L, Rosier JF, Safrany G, Selzer E, Verheij M, Hendry JH.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):551-61.

PMID:
16414371
[PubMed - indexed for MEDLINE]
4.

Effects of 2-chloro-2'-deoxyadenosine on the cell cycle in the human leukemia EHEB cell line.

Cardoen S, Van den Neste E, Smal C, Rosier JF, Ferrant A, Van den Berghe G, Bontemps F.

Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1425-9.

PMID:
15571271
[PubMed - indexed for MEDLINE]
5.

Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas.

Rosier JF, Bruniaux M, Husson B, Octave-Prignot M, Beauduin M, Grégoire V.

Radiother Oncol. 2004 Jan;70(1):55-61.

PMID:
15036853
[PubMed - indexed for MEDLINE]
6.

The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.

Rosier JF, Michaux L, Ameye G, Cedervall B, Libouton JM, Octave-Prignot M, Verellen-Dumoulin C, Scalliet P, Grégoire V.

Mutat Res. 2003 Jun 19;527(1-2):15-26.

PMID:
12787910
[PubMed - indexed for MEDLINE]
7.

Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.

Grégoire V, Rosier JF, De Bast M, Bruniaux M, De Coster B, Octave-Prignot M, Scalliet P.

Radiother Oncol. 2002 Jun;63(3):329-38.

PMID:
12142097
[PubMed - indexed for MEDLINE]
8.

A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma.

Grégoire V, Ang KK, Rosier JF, Beauduin M, Garden AS, Hamoir M, Hittelman WN, Humblet Y, Khuri FR, Milas L, Mitine C, Scalliet P.

Radiother Oncol. 2002 May;63(2):187-93.

PMID:
12063008
[PubMed - indexed for MEDLINE]
9.

2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.

Van Den Neste E, Cardoen S, Husson B, Rosier JF, Delacauw A, Ferrant A, Van den Berghe G, Bontemps F.

Leukemia. 2002 Jan;16(1):36-43.

PMID:
11840261
[PubMed - indexed for MEDLINE]
Free Article
10.

Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.

Cardoen S, Van Den Neste E, Smal C, Rosier JF, Delacauw A, Ferrant A, Van den Berghe G, Bontemps F.

Clin Cancer Res. 2001 Nov;7(11):3559-66.

PMID:
11705877
[PubMed - indexed for MEDLINE]
Free Article
11.

Proton RBE for early intestinal tolerance in mice after fractionated irradiation.

Gueulette J, Slabbert JP, Böhm L, De Coster BM, Rosier JF, Octave-Prignot M, Ruifrok A, Schreuder AN, Wambersie A, Scalliet P, Jones DT.

Radiother Oncol. 2001 Nov;61(2):177-84.

PMID:
11690684
[PubMed - indexed for MEDLINE]
12.

Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy.

Grégoire V, Hamoir M, Rosier JF, Counoy H, Eeckhoudt L, Neymark N, Scalliet P.

Radiother Oncol. 1999 Oct;53(1):1-13.

PMID:
10624847
[PubMed - indexed for MEDLINE]
14.

Chemo-radiotherapy: radiosensitizing nucleoside analogues (review).

Gregoire V, Hittelman WN, Rosier JF, Milas L.

Oncol Rep. 1999 Sep-Oct;6(5):949-57. Review.

PMID:
10425285
[PubMed - indexed for MEDLINE]
15.

The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.

Rosier JF, Beauduin M, Bruniaux M, de Bast M, de Coster B, Octave-Prignot M, Scalliet P, Grégoire V.

Int J Radiat Biol. 1999 Feb;75(2):245-51.

PMID:
10072186
[PubMed - indexed for MEDLINE]
16.

Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation.

Rosier JF, Grégoire V, Counoy H, Octave-Prignot M, Rombaut P, Scalliet P, Vanderlinden F, Hamoir M.

Radiother Oncol. 1998 Aug;48(2):175-83.

PMID:
9783889
[PubMed - indexed for MEDLINE]
17.

Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.

Grégoire V, Beauduin M, Rosier JF, De Coster B, Bruniaux M, Octave-Prignot M, Scalliet P.

Br J Cancer. 1997;76(10):1315-21. Erratum in: Br J Cancer 1998 Mar;77(6):1026.

PMID:
9374377
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk